Safety and antiviral activity of lopinavir/ritonavir-based therapy in human immunodeficiency virus type 1 (HIV-1) infection.
about
Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection.Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adultsTreatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure.Association between ABCC2 polymorphism and lopinavir accumulation in peripheral blood mononuclear cells of HIV-infected patients.Coadministration with lopinavir and ritonavir decreases exposure to BILR 355, a nonnucleoside reverse transcriptase inhibitor, in healthy volunteers.Lopinavir/ritonavir versus darunavir plus ritonavir for HIV infection: a cost-effectiveness analysis for the United States.Genotypic resistance to lopinavir and fosamprenavir with or without ritonavir of clinical isolates from patients failing protease inhibitors-containing HAART regimens: prevalence and predictors.Metabolic effects of initiating lopinavir/ritonavir-based regimens among young childrenInhibitors of HIV-1 protease: 10 years after
P2860
Q34594695-E0939A1B-567D-418B-945F-B7C1D7694352Q36144257-685C808B-8419-4D2B-BEFD-2AF43E3AF220Q42938439-D0F2C3D1-A315-41B7-8CFE-F08048D6F1F1Q43258274-AA6515AF-9C05-41B2-AD80-F7BD385D0133Q43774080-9FF35375-3B49-43DB-9158-A22E1A173B29Q45055651-AF8F3FE3-0744-45B3-A5DC-FC62647B7052Q51907858-44C52C0F-BAE5-4A5B-86C0-3AF75AE79155Q57795380-CB6E98A0-2331-423E-9660-ECE582F0785CQ58389026-124610E0-8D0E-46FF-A8F3-0C93DBA6657E
P2860
Safety and antiviral activity of lopinavir/ritonavir-based therapy in human immunodeficiency virus type 1 (HIV-1) infection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Safety and antiviral activity ...... irus type 1 (HIV-1) infection.
@ast
Safety and antiviral activity ...... irus type 1 (HIV-1) infection.
@en
type
label
Safety and antiviral activity ...... irus type 1 (HIV-1) infection.
@ast
Safety and antiviral activity ...... irus type 1 (HIV-1) infection.
@en
prefLabel
Safety and antiviral activity ...... irus type 1 (HIV-1) infection.
@ast
Safety and antiviral activity ...... irus type 1 (HIV-1) infection.
@en
P356
P1476
Safety and antiviral activity ...... irus type 1 (HIV-1) infection.
@en
P2093
Charles B Hicks
Susan S Kaplan
P304
P356
10.1093/JAC/DKI209
P407
P577
2005-06-30T00:00:00Z